• Clinically Proven Formula. Study shows that PRN DE Omega-benefits is effective to relieve symptoms associated with occasional dry eye. *
• Recommended by Top Physicians. Dry Eye Omega Benefits Liquid is endorsed and used by leading ophthalmologists and optometrists as a preferred solution for maintaining a healthy ocular surface.
• The right form and serving. 1 teaspoon per day of Dry Eye Omega Benefits Liquid provides 2,240 grams of EPA/DHA in the re-esterified triglyceride form (rTG).
• Re-Esterified Triglyceride (rTG) Form for Maximum Absorption. Study shows that the form of Omega-3 used by PRN DE Omega-Benefits is the most easily absorbed form.**
• Patented Formulation for a Soothing, Healthy Tear.
U.S. Patent No. 9,115,078: Compositions for Improving the Quality of the Meibum Composition of Inflamed or Dysfunctional Meibomian Glands
U.S. Patent No. 9,381,183: Methods for Improving the Quality of the Meibum Composition of Inflamed or Dysfunctional Meibomian Glands.
• Third-party tested for purity. Dry Eye Omega Benefits Liquid is manufactured in Norway according to cGMP standards in facilities that are pharmaceutically certified. Our proprietary molecular distillation process guarantees a product of exceptional purity as compared to non- distilled Omega-3 products commonly found over the counter.
• Why it works
Study shows that PRN Dry Eye Omega Benefits® is effective to relieve symptoms associated with occasional dry eye.*
– Significantly improves occasional dry eye discomforts such as grittiness, dryness, and burning
– Improves tear film quality, contributing to overall eye comfort and stable vision
– Ensures tears are healthy as part of creating a healthy surface for surgery
– Provides critical nutrition to produce healthy, soothing tears
– Can produce optimal levels of omega-3s in 90 days

• How it works
Omega-3 deficient glands become inflamed and clogged which accelerates tear evaporation and dryness due to missing oil.

After an initial 90 days of proper Omega-3 nutrition, followed by long term use, healthy tear film production is restored along with normalized oil glands.

Study shows that the form of Omega-3 used by PRN DE Omega-Benefits is the most easily absorbed form.**

Frequently asked questions

Q: What is an rTG fish oil?
A: Many omega-3s are in a synthetic (ester) or unpurified form, which is difficult to absorb and leaves a fishy odor/aftertaste. PRN Omega-3s are in an ultra-purified triglyceride (rTG) form, which is a similar form to a piece of fish, but without the impurities. This form is easier for your body to absorb and micro-distilled to remove contaminants like PCBs, lead, mercury and more. PRN omega-3s are manufactured in a cGMP facility.

Q: When will I see an effect?
A: It will take about 60-90 days for Omega-3s to become fully saturated on a cellular level and therefore, to notice a difference. You may not notice the improvement taking place inside your body, but improvement can be measured by your doctor.

Q: Are there any side effects when taking this product?
A: PRN Omega-3s are clinically tested, safe and effective. Your body will recognize it just as if you were eating a piece of fish. Nevertheless, some people may experience side effects, but usually they are usually mild.

Q: Why can’t I just eat fish?
A: The American Heart Association and the American Cardiology Association recommend 2-3 grams of omega-3s daily (EPA+DHA). Taking 3 soft gels of PRN Omega-3s each day for a week is equivalent to eating 37 cans of tuna. Eating this much fish may cause an increased risk for mercury poisoning. Other fish that can be purchased in the stores are mostly farm raised which have little Omega-3s or wild caught which are optimal but are contaminated with harmful PCBs, dioxins, mercury, etc.

* Epitropoulos A., et al., Cornea. 2016 Sep; 35(9): 1185–1191. Published online 2016 Jul 20. doi: 10.1097/ICO.0000000000000940
** Dyerberg J et al, Bioavailability of marine n-3 acid formulations, Prostaglandins Leukotrines Essent. Fatty Acids (2010), doi: 10.1016/j.plefa.2010.06.007.

* Epitropoulos A., et al., Cornea. 2016 Sep; 35(9): 1185–1191. Published online 2016 Jul 20. doi: 10.1097/ICO.0000000000000940
** Dyerberg J et al, Bioavailability of marine n-3 acid formulations, Prostaglandins Leukotrines Essent. Fatty Acids (2010), doi: 10.1016/j.plefa.2010.06.007.